Vein of Marshall ethanol infusion combine with radiofrequency ablation for persistent atrial fibrillation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029235

Enrollment

Unknown

Registered

2020-01-19

Start date

2020-02-01

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Test group:VOM ethanol infusion combined with radiofrequency ablation

Positive control group:Radiofrequency ablation

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-70 years; 2. Persistent AF without previous ablation; 3. Drug refractory persistent AF; 4. Left atrial inner diameter <= 60mm.

Exclusion criteria

Exclusion criteria: 1. Previous radiofrequency ablation; 2. Combined with left atrial thrombus; 3. Heart failure with reduced ejection fraction; 4. Combined with severe structural heart disease or thyroid dysfunction.

Design outcomes

Primary

Measure	Time frame
AF recurrence rate;	—

Secondary

Measure	Time frame
Termination rate of AF during ablation;acute rate of mitral isthmus block;Procedure time, X-ray exposure time, and ablation time;Incidence of ablation-related complications;	—

Countries

China

Contacts

Public ContactJiang Weifeng

Shanghai Chest Hospital

wf.jiang@hotmail.com+86 15802146464

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026